Literature DB >> 20494488

[Changes in bone mass with atorvastatin. BM AND AT study].

Mariano Blasco Valle, José María Ferreras Amez, Ángel Vicente Molinero, Víctor Abadía Gallego, Marco Sarrat Torres.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20494488      PMCID： PMC7024911          DOI： 10.1016/j.aprim.2010.01.026

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  6 in total

Review 1.  Statins: under investigation for increasing bone mineral density and augmenting fracture healing.

Authors:  Quen Oak Tang; Gui Tong Tran; Zakareya Gamie; Simon Graham; Evaggelos Tsialogiannis; Evgenios Tsiridis; Tobias Linder; Eleftherios Tsiridis
Journal:  Expert Opin Investig Drugs       Date:  2008-10       Impact factor: 6.206

2.  Stimulation of bone formation in vitro and in rodents by statins.

Authors:  G Mundy; R Garrett; S Harris; J Chan; D Chen; G Rossini; B Boyce; M Zhao; G Gutierrez
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

3.  Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study.

Authors:  Andrea Z LaCroix; Jane A Cauley; Mary Pettinger; Judith Hsia; Douglas C Bauer; Joan McGowan; Zhao Chen; Cora E Lewis; S Gene McNeeley; Maureen D Passaro; Rebecca D Jackson
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

4.  Effect of atorvastatin on bone mineral density in patients with acute coronary syndrome.

Authors:  J L Pérez-Castrillón; L Abad; G Vega; A Sanz-Cantalapiedra; M García-Porrero; F Pinacho; A Dueñas
Journal:  Eur Rev Med Pharmacol Sci       Date:  2008 Mar-Apr       Impact factor: 3.507

5.  Alendronate in the prevention of osteoporosis: 7-year follow-up.

Authors:  P N Sambrook; J P Rodriguez; R D Wasnich; M M Luckey; A Kaur; L Meng; A Lombardi
Journal:  Osteoporos Int       Date:  2004-02-13       Impact factor: 4.507

6.  Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial.

Authors:  Henry G Bone; Douglas P Kiel; Robert S Lindsay; E Michael Lewiecki; Michael A Bolognese; Elizabeth T Leary; Wing Lowe; Michael R McClung
Journal:  J Clin Endocrinol Metab       Date:  2007-08-28       Impact factor: 5.958
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.